Alexander Eresko

Dr. Alexander Eresko


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2024 in Chemistry Proceedings
Verified
Conference Paper
Open access
PDF file
AEAlexander Eresko
Alexander Eresko
ERElena Raksha
Elena Raksha
Dmitry FilimonovDmitry Filimonov
Dmitry Filimonov
NTNadezhda N. Trubnikova
Nadezhda N. Trubnikova
IKIrina Kisilenko
Irina Kisilenko
DCDorota Marta Chudoba
Dorota Marta Chudoba
Molecular modelling of the structure and evaluation of the chemical shifts of 1H and 13C nuclei were performed for the 4-[4-(2-aminoethoxy)benzyl]aniline, which is a structural analogue of thyronamines. The intramolecular dynamics of the key structural fragments of 4-[4-(2-aminoethoxy)benzyl]aniline were studied by the PM6-DH2 method as well as at the B3LYP/6-31G(d,p) level of theory. Nonspecific solvation with dimethyl sulfoxide was taken into account within the polarized continuum model. Specific solvation by one and two DMSO molecules was considered within supermolecule approximation. Chemical shifts of the 1H and 13C nuclei were estimated for the most stable conformer of 4-[4-(2-aminoethoxy)benzyl]aniline as well as for its solvates with DMSO. Calculated chemical shifts of the 1H and 13C nuclei are in good agreement with the experimental ones obtained for 4-[4-(2-aminoethoxy)benzyl]aniline in DMSO-d6 solution. Some aspects of the bioactivity of 4-[4-(2-aminoethoxy)benzyl]aniline are discussed.

16 August 2025 in Life
Verified
Journal Article
Open access
PDF file
Dmitry FilimonovDmitry Filimonov
Dmitry Filimonov
VMVitaly V. Morozov
Vitaly V. Morozov
RIRoman V. Ishchenko
Roman V. Ishchenko
AEAlexander Eresko
Alexander Eresko
NTNadezhda N. Trubnikova
Nadezhda N. Trubnikova
DKDmitry A. Kudlay
Dmitry A. Kudlay
The global burden of ischemic stroke requires a search for new factors that affect its risk and outcomes. Recent studies have shown that triiodothyronine could potentiate favorable stroke outcomes, but the reason for this is still unclear. To clarify the effects of the free triiodothyronine (fT3) level on stroke outcomes, we adopted a Mendelian randomization (MR) approach to evaluate their causal relationship. The genetic variants associated with the free triiodothyronine (fT3) level were obtained from the ThyroidOmics Consortium. Thirteen single-nucleotide polymorphisms, genetically predicting the fT3 level with a significance of p < 10−7, were adopted for MR analysis. Summary-level data for ischemic stroke outcomes (reported as a continuous variable, namely the modified Rankin score 3 months after stroke) was obtained from the GISCOME network. MR analyses were performed using the TwoSampleMR framework. The inverse-variance weighting method of MR analysis showed that a genetically predicted increase in fT3 level is associated with a reduction in ordinal Modified Rankin Scale scores (OR = 0.581, 95% CI 0.37–0.92, p = 0.0183). This study showed that higher fT3 levels could be causally associated with more favorable ischemic stroke outcomes and provides more evidence for the possibility of using thyroid hormone (TH) analogs to improve stroke outcomes.

17 February 2026 in Antioxidants
Verified
Journal Article
Open access
PDF file
Dmitry FilimonovDmitry Filimonov
Dmitry Filimonov
AEAlexander Eresko
Alexander Eresko
NTNadezhda N. Trubnikova
Nadezhda N. Trubnikova
IKIrina Kisilenko
Irina Kisilenko
MBMargarita A. Belotserkovskaya
Margarita A. Belotserkovskaya
DCDorota Marta Chudoba
Dorota Marta Chudoba
The release of reactive oxygen species accompanying oxidative stress is one of the most significant damaging mechanisms during brain ischemia. Some aspects of the neuroprotective activity of the thyronamine T0AM synthetic analogue, 4-[4-(2-aminoethoxy)benzyl]aniline (ABA), were studied and discussed in two independent experiments using a model of acute cerebral ischemia. Antioxidant effects were evaluated in adult male and female Wistar rats (Rattus norvegicus), while neurological outcomes were assessed in adult male outbred white rats. Administration of the ABA in a rat brain hemisphere ischemia model was associated with significant changes in redox markers: malondialdehyde, glutathione peroxidase and superoxide dismutase levels in the ischemic hemisphere. Also, the introduction of ABA into the model of acute cerebral ischemia contributed to a reduction in neurological deficit compared to untreated controls. It was revealed that the considered thyronamine T0AM analogue could control redox status in acute brain ischemia. Mono protonated form of ABA (ABA-H+) is considered to be the main species at pH 6.9–7.2. Structural models of the neutral (ABA), protonated (ABA-H+) thyronamine and its solvate (DMSO…ABA-H+) were used in DFT calculations, followed by estimation of molecular and supramolecular level descriptors.

28 October 2026 in Chemistry Proceedings
Verified
Conference Paper
Open access
PDF file
AEAlexander Eresko
Alexander Eresko
ERElena Raksha
Elena Raksha
Dmitry FilimonovDmitry Filimonov
Dmitry Filimonov
YBYuliya Berestneva
Yuliya Berestneva
NTNadezhda N. Trubnikova
Nadezhda N. Trubnikova
RIRoman V. Ishchenko
Roman V. Ishchenko
Experimental and molecular modelling data on chemical shifts of 1H and 13C nuclei are presented for the 4-[4-(2-aminoethoxy)phenoxy]aniline (APA) dihydrochloride, which is a new structural analogue of thyronamine T0AM. In our study we treat two structural models of the APA—its protonated form [H-APA-H]2+ and neutral dihydrochloride APA·2HCl. Chemical shifts in the 1H and 13C nuclei were estimated for the basic conformers of [H-APA-H]2+ and APA·2HCl models. Nonspecific solvation with DMSO was taken into account within the polarized continuum model. Calculated chemical shifts in the 1H and 13C nuclei were in good agreement with the experimental ones obtained for 4-[4-(2-aminoethoxy)phenoxy]aniline dihydrochloride in DMSO-d6 solution.